1 / 2

Antibody Production Market Size & Growth

The research conducted by GME predicted that the Global Antibody Production Market will expand at a high CAGR value during the forecast period [2021 to 2026]. The rise in the lifestyle concerning diseases like cancer also has the potential use of monoclonal antibodies (mAb) and the expansion of the market is also reliable on the new manufacturing facilities dedicated to antibody production.<br>Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on "Antibody Production Market - Forecast to 2026" <br>https://www.globalmarketestimates.com/market-report/global-antibody-production-market-2822<br>By Process (Upstream Processing, Downstream Processing, Filtration), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Laboratories) By Region (North America, Asia Pacific, Europe, Central & South America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis<br>Key Market Insights:<br>u2022tDownstream processing would be occupying a major space owing to its wide importance in the biotech sector <br>u2022tDiagnostic laboratories would be the second-largest user of the antibodies <br>u2022tSerum Institute, Sun Pharma, Sumit Biosciences, Biogeniux, Merck KGaA, GE Healthcare, Abcam Plc, Sino Biological, Genscript, Nippon Kayaku, and Chugai are key players functioning in this market.<br>Browser the report @ https://www.globalmarketestimates.com/market-report/global-antibody-production-market-2822<br>Process Outlook (Revenue, USD Million, 2021 - 2026)<br>u2022tUpstream Processing<br>u2022tDownstream Processing <br>u2022tFiltration<br><br>End-User Outlook (Revenue, USD Million, 2021-2026)<br>u2022tPharmaceutical and Biotechnology Companies <br>u2022tResearch Institutes<br>u2022tDiagnostic Laboratories<br>Regional Outlook (Revenue, USD Million, 2021 - 2026)<br>North America<br>u2022tU.S <br>u2022tCanada<br>u2022tMexico<br>Europe<br>u2022tGermany<br>u2022tUK<br>u2022tFrance<br>u2022tSpain<br>u2022tItaly<br>u2022tRest of Europe<br>Asia Pacific<br>u2022tChina<br>u2022tIndia<br>u2022tJapan<br>u2022tSouth Korea<br>u2022tAustralia<br>u2022tRest of APAC<br>Central & South America<br>u2022tBrazil<br>u2022tArgentina<br>u2022tChile<br>u2022tRest of CSA<br>Middle East & Africa<br>u2022tSaudi Arabia<br>u2022tSouth Africa<br>u2022tUAE<br>u2022tRest of MEA<br><br>Contact: Tracy Simon<br>Email address: tracy.simon@globalmarketestimates.com <br>Phone Number: 16026667238<br><br><br>

Download Presentation

Antibody Production Market Size & Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antibody Production Market Analysis - Forecasts to 2026 The research conducted by GME predicted that the Global Antibody Production Market will expand at a high CAGR value during the forecast period [2021 to 2026]. The rise in the lifestyle concerning diseases like cancer also has the potential use of monoclonal antibodies (mAb) and the expansion of the market is also reliable on the new manufacturing facilities dedicated to antibody production. Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on "Antibody Production Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-antibody-production-market- 2822 By Process (Upstream Processing, Downstream Processing, Filtration), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Laboratories) By Region (North America, Asia Pacific, Europe, Central & South America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis Key Market Insights: •Downstream processing would be occupying a major space owing to its wide importance in the biotech sector •Diagnostic laboratories would be the second-largest user of the antibodies •Serum Institute, Sun Pharma, Sumit Biosciences, Biogeniux, Merck KGaA, GE Healthcare, Abcam Plc, Sino Biological, Genscript, Nippon Kayaku, and Chugai are key players functioning in this market. Browser the report @ https://www.globalmarketestimates.com/market-report/global- antibody-production-market-2822 Process Outlook (Revenue, USD Million, 2021 - 2026) •Upstream Processing •Downstream Processing •Filtration End-User Outlook (Revenue, USD Million, 2021-2026) •Pharmaceutical and Biotechnology Companies •Research Institutes •Diagnostic Laboratories Regional Outlook (Revenue, USD Million, 2021 - 2026) North America •U.S

  2. •Canada •Mexico Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia Pacific •China •India •Japan •South Korea •Australia •Rest of APAC Central & South America •Brazil •Argentina •Chile •Rest of CSA Middle East & Africa •Saudi Arabia •South Africa •UAE •Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238

More Related